CNR1 and breast cancer: CBD (5 μM) decreased the survival of the MDA-MB-231 breast cancer cell line in a CB1/CB2-independent manner [22], although the antiproliferative effect was partially CB2-dependent when CBD was added at a higher concentration (10 μM) [9].